华蟾素胶囊和芬太尼透皮贴剂联合治疗肿瘤骨转移中重度癌痛的效果研究

doi:10.12114/j.issn.1007-9572.2019.00.269

摘要/Abstract

摘要： 背景　恶性肿瘤骨转移是中晚期肿瘤患者常见的并发症，是临床上面临的一大难题。目前三阶梯镇痛治疗取得了一定的疗效，但由于阿片类药物长期使用可导致成瘾、便秘等不良反应，严重影响患者的依从性和治疗效果。目的　评估华蟾素胶囊和芬太尼透皮贴剂联合治疗恶性肿瘤骨转移癌痛患者的有效性和安全性。方法　选取2016年4月—2018年6月由同济大学附属杨浦医院和上海市皮肤病医院各个临床科室收治的经病理学、影像学确诊的恶性肿瘤骨转移患者298例，采用双盲随机对照试验将其分为对照组和观察组，其中观察组147例，对照组151例。观察组予以华蟾素胶囊和芬太尼透皮贴剂联合治疗，对照组予以口服安慰剂和芬太尼透皮贴剂治疗；分别于治疗前、治疗第7、14、30天比较两组患者视觉模拟评分（VAS）、24 h艾司唑仑用量、生存质量评分，治疗第7天评价疼痛缓解率以及治疗期间不良反应发生情况。结果　治疗第7、14、30天，观察组VAS均低于对照组，艾司唑仑用量均小于对照组，生活质量评分均高于对照组（P<0.05）。治疗第7天，观察组治疗有效率为72.1%（106/147），高于对照组的49.7%（75/151）（χ2=15.729，P<0.001）。观察组不良反应发生率为12.2%（18/147），对照组为11.9%（18/151），两组不良反应发生率比较，差异无统计学意义（χ2=0.007，P=0.932）。两组治疗后血常规、尿常规、便常规、肝肾功能、电解质较治疗前均无明显异常。结论　华蟾素胶囊和芬太尼透皮贴剂联合治疗恶性肿瘤骨转移中重度癌痛，较单纯应用芬太尼透皮贴剂有更好的止痛效果，安全性高。

关键词: 华蟾素, 芬太尼, 镇痛, 骨转移癌痛, 肿瘤转移, 治疗结果

Abstract: Background　Bone metastasis is a common complication among patients with advanced tumors and a difficult issue to treat in clinic.At present，three-step analgesia treatment has achieved a certain effect，but the long-term use of opioid drugs can lead to addiction，constipation and other toxic side effects，which will affect patients' compliance and treatment results seriously.Objective　To evaluate the efficacy and safety of cinobufagin capsule and fentanyl transdermal patch in the treatment of cancer pain from bone metastasis.Methods　A total of 298 patients with bone metastasis diagnosed by pathology and imaging were selected from Yangpu Hospital，Tongji University and Shanghai Dermatological Hospital from April 2016 to June 2018.A double blind randomized controlled trial was used to divide them into two groups：observation group（147 cases） and control group（151 cases）．The observation group was treated with cinobufagin capsule and fentanyl transdermal patch，while the control group was treated with oral placebo and fentanyl transdermal patch.The visual analogue scores（VAS），24 h estazolam usage，quality of life（QoL） score before treatment and at 7，14，30 days after treatment，pain relief rate at 7 days after treatment and side effects during treatment were compared between the two groups.Results　On the 7th，14th and 30th day after treatment，the VAS and the dosage of estazolam in the observation group was lower than those in the control group（P<0.05）．Meantime，the quality of life score in the observation group was higher than that in the control group（P<0.05）．On the 7th day of treatment，the effective rate in the observation group was 72.1%（106/147），which was higher than that in the control group 〔49.7%（75/151）（χ2=15.729，P<0.001）〕.There was no significant difference of the incidence of toxic and side effects between the two groups，which was 12.2%（18/147） in the observation group and 11.9%（18/151） in the control group（χ2=0.007，P=0.932）．In both groups，there were no significant abnormality of the blood test，urine test，fecal test and electrolytes of liver and kidney function before and after treatment.Conclusion　The combination of cinobufagin capsule and fentanyl transdermal patch in the treatment of moderate/severe cancer pain from bone metastasis is more effective and safer than fentanyl transdermal patch solely used in the treatment.

Key words: Cinobufacin, Fentanyli, Analgesia, Metastatic bone cancer pain, Neoplasm metastasis, Treatment outcome

杨森,赵华新,王朝昕,等. 华蟾素胶囊和芬太尼透皮贴剂联合治疗肿瘤骨转移中重度癌痛的效果研究[J]. 中国全科医学, 2019, 22(32): 3993-3996. DOI: 10.12114/j.issn.1007-9572.2019.00.269.
YANG Sen,ZHAO Huaxin,WANG Zhaoxin, et al. Efficacy of Cinobufacin Capsule Combined with Fentanyl Transdermal Patch in the Treatment of Moderate and Severe Cancer Pain with Bone Metastasis　[J]. Chinese General Practice, 2019, 22(32): 3993-3996. DOI: 10.12114/j.issn.1007-9572.2019.00.269.

参考文献

［1］VON MOOS R，COSTA L，RIPAMONTI C I，et al．Improving quality of life in patients with advanced cancer：targeting metastatic bone pain［J］．Eur J Cancer，2017，71：80-94．DOI：10.1016/j.ejca.2016.10.021.
［2］BUEHLMANN D，GRANDJEAN J，XANDRY J，et al．Longitudinal resting-state functional magnetic resonance imaging in a mouse model of metastatic bone cancer reveals distinct functional reorganizations along a developing chronic pain state［J］．Pain，2018，159（4）：719-727．DOI：10.1097/j.pain.0000000000001148.
［3］王友青，白向丽，宋星，等．111例癌性疼痛患者社区治疗临床分析［J］．中国全科医学，2018，21（26）：3228-3230.DOI：10.3969/j.issn.1007-9572.2018.00.173.
WANG Y Q，BAI X L，SONG X，et al．Clinical analysis of community-based care for 111 cases of cancer pain ［J］．Chinese General Practice，2018，21（26）：3228-3230.DOI：10.3969/j.issn.1007-9572.2018.00.173.
［4］BOUHASSIRA D，LUPORSI E，KRAKOWSKI I.Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer［J］．Pain，2017，158（6）：1118-1125．DOI：10.1097/j.pain.0000000000000895.
［5］高波，吴旭，边宝林.华蟾素注射液多肽成分分析和镇痛活性评价［J］．中华中医药杂志，2018，33（7）：3134-3137.
GAO B，WU X，BIAN B L.Analysis and evaluation of the analgesic activity of polypeptides from cinobufacini injection［J］．China Journal of Traditional Chinese Medicine and Pharmacy，2018，33（7）：3134-3137.
［6］马海锋.华蟾素胶囊对直肠癌放疗后气阴两虚证患者的疗效及对免疫功能的影响［J］．中国中西医结合消化杂志，2014，22（4）：185-188．DOI：10.3969/j.issn.1671-038X.2014.04.04.
MA H F.Effect of Huachansu capsules on rectal cancer patients after radiotherapy with Qi-Yin deficiency syndrome as well as their immune function［J］．Chinese Journal of Integrated Traditional and Western Medicine on Digestion，2014，22（4）：185-188．DOI：10.3969/j.issn.1671-038X.2014.04.04.
［7］肖晓光，梅齐，李扬，等．华蟾素胶囊联合化疗治疗晚期肺癌的临床研究［J］．实用肿瘤杂志，2015，30（5）：469-473．DOI：10.13267/j.cnki.syzlzz.2015.05.019.
XIAO X G，MEI Q，LI Y，et al．Cinobufacini capsule combined with chemotherapy in treatment of patients with advanced lung cancer［J］．Journal of Practical Oncology，2015，30（5）：469-473．DOI：10.13267/j.cnki.syzlzz.2015.05.019.
［8］FISHER S B，CHIANG Y J，FEIG B W，et al．Comparative performance of the 7th and 8th editions of the American Joint Committee on cancer staging systems for soft tissue sarcoma of the trunk and extremities［J］．Ann Surg Oncol，2018，25（5）：1126-1132．DOI：10.1245/s10434-018-6378-9.
［9］LU F，SONG L，XIE T，et al．Current status of malignant neuropathic pain in Chinese patients with cancer：report of a hospital-based investigation of prevalence，etiology，assessment，and treatment［J］．Pain Pract，2017，17（1）：88-98．DOI：10.1111/papr.12422.
［10］REMENIUK B，KING T，SUKHTANKAR D，et al．Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain［J］．Pain，2018，159（4）：684-698．DOI：10.1097/j.pain.0000000000001139.
［11］SHINOZAKI M，HOON D S，GIULIANO A E，et al．Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis［J］．Clin Cancer Res，2005，11（6）：2156-2162．DOI：10.1158/1078-0432.CCR-04-1810.
［12］周磊，邵燕儿，朱泽浩，等．华蟾素胶囊联合盐酸埃克替尼片治疗晚期非小细胞肺癌临床效果研究［J］．中国全科医学，2018，21（9）：1047-1052．DOI：10.3969/j.issn.1007-9572.2017.00.210.
ZHOU L，SHAO Y E，ZHU Z H，et al．Effect of cinobufacini capsule combined with lcotinib in the treatment of advanced non-small cell lung cancer［J］．Chinese General Practice，2018，21（9）：1047-1052．DOI：10.3969/j.issn.1007-9572.2017.00.210.
［13］杨兴肖，李幼梅，宋姮，等．华蟾素注射液联合放疗对食管癌细胞增殖与周期的影响［J］．中国实验方剂学杂志，2016，22（16）：128-133．DOI：10.13422/j.cnki.syfjx.2016160128.
YANG X X，LI Y M，SONG H，et al．Effect of cinobufacini injection combined with radiotherapy on proliferation and cell cycle of human esophageal carcinoma［J］．Chinese Journal of Experimental Traditional Medical Formulae，2016，22（16）：128-133．DOI：10.13422/j.cnki.syfjx.2016160128.
［14］雷金华，喻雄杰，狄全书，等．华蟾素胶囊联合放射治疗用于中晚期鼻咽癌的临床观察［J］．中国药房，2017，28（5）：633-635．DOI：10.6039/j.issn.1001-0408.2017.05.15.
LEI J H，YU X J，DI Q S，et al．Clinical observation of cinobufacin capsules combined with radiotherapy in the treatment of median and advanced nasopharyngeal carcinoma［J］．China Pharmacy，2017，28（5）：633-635．DOI：10.6039/j.issn.1001-0408.2017.05.15.
［15］王静，陶熔，吴广银，等．复方苦参注射液和芬太尼透皮贴剂联合治疗老年晚期胃癌癌性疼痛的疗效［J］．中华老年医学杂志，2017，36（6）：677-679．DOI：10.3760/cma.j.issn.0254-9026.2017.06.018.
WANG J，TAO R，WU G Y，et al．Therapeutic efficacy of compound matrine injection combined with fentanyl transdermal patch on cancer pain in elderly patients with advanced gastric cancer［J］．Chinese Journal of Geriatrics，2017，36（6）：677-679．DOI：10.3760/cma.j.issn.0254-9026.2017.06.018.
［16］郑翰林，申鹏飞，朱腾飞，等．骨转移癌217例临床分析［J］．实用医学杂志，2017，33（18）：3070-3074．DOI：10.3969/j.issn.1006-5725.2017.18.023.
ZHENG H L，SHEN P F，ZHU T F，et al．Clinical analysis of 217 patients with metastatic carcinoma of bone［J］．The Journal of Practical Medicine，2017，33（18）：3070-3074．DOI：10.3969/j.issn.1006-5725.2017.18.023.
CHENG X J，SHAO Y J，WANG K.Efficacy of percutaneous vertebroplasty with radiotherapy for bone metastasis pain［J］．Chinese Journal of Clinical Oncology，2016，43（9）：371-375．DOI：10.3969/j.issn.1000-8179.2016.09.039.
［13］IQBAL T，SHI L，WANG L，et al．Development of finite element model for customized prostheses design for patient with pelvic bone tumor［J］．Proc Inst Mech Eng H，2017，231（6）：525-533．DOI：10.1177/0954411917692009.
［14］王华伟，王文萍，喻明，等．中医外治及联合吗啡治疗骨转移癌痛的临床研究［J］．中华中医药杂志，2014，29（9）：3018-3021.
WANG H W，WANG W P，YU M，et al．Clinical research on TCM external treatment combined with morphine in treatment of the pain of bone metastases［J］．China Journal of Traditional Chinese Medicine and Pharmacy，2014，29（9）：3018-3021.
［15］BENNETT M I.Mechanism-based cancer-pain therapy［J］．Pain，2017，158（Suppl 1）：S74-78．DOI：10.1097/j.pain.0000000000000825.
［16］CHWISTEK M.Recent advances in understanding and managing cancer pain［J］．F1000Res，2017，6：945．DOI：10.12688/f1000research.10817.1.
［17］WIFFEN P J，COOPER T E，ANDERSON A K，et al．Opioids for cancer-related pain in children and adolescents［J］．Cochrane Database Syst Rev，2017，7：CD012564．DOI：10.1002/14651858.CD012564.
［18］李俊，丁纪元，黄静.盐酸羟考酮缓释片联合生物电刺激治疗中重度癌痛的疗效及治疗费用分析［J］．中国全科医学，2014，17（3）：325-327．DOI：10.3969/j.issn.1007-9572.2014.03.021.
LI J，DING J Y，HUANG J.Curative effects and costs of oxycontin combined with bio-electric stimulation therapy in treatment of moderate or severe cancer pain［J］．Chinese General Practice，2014，17（3）：325-327．DOI：10.3969/j.issn.1007-9572.2014.03.021.
［19］鲍关爱，周杰，杨丹红，等．针灸治疗癌性疼痛的常用参数浅析［J］．上海针灸杂志，2017，36（2）：236-241．DOI：10.13460/j.issn.1005-0957.2017.02.0236.
BAO G A，ZHOU J，YANG D H，et al．Preliminary analysis of common parameters for acupuncture treatment of cancer pain［J］．Shanghai Journal of Acupuncture and Moxibustion，2017，36（2）：236-241．DOI：10.13460/j.issn.1005-0957.2017.02.0236.
［20］FERREIRA A P，COSTA D R，OLIVEIRA A I，et al．Short-term transcutaneous electrical nerve stimulation reduces pain and improves the masticatory muscle activity in temporomandibular disorder patients：a randomized controlled trial［J］．J Appl Oral Sci，2017，25（2）：112-120．DOI：10.1590/1678-77572016-0173.

[1]	金子开, 王旭, 孙凯, 王艳国, 师彬, 罗杰, 朱立国, 魏戌. 手法治疗颈椎病中枢镇痛机制研究进展[J]. 中国全科医学, 2023, 26(02): 225-232.
[2]	曾媛, 王国华, 杨勇. 氢吗啡酮、舒芬太尼及吗啡在难治性癌痛合并口服困难患者静脉自控镇痛中的疗效比较研究[J]. 中国全科医学, 2022, 25(36): 4537-4545.
[3]	周琴飞, 龚黎燕. 盐酸美沙酮片治疗难治性癌痛患者的临床观察研究[J]. 中国全科医学, 2022, 25(32): 4023-4028.
[4]	洪子强, 金大成, 白向豆, 崔百强, 苟云久. 多原发肺癌诊断与治疗的最新研究进展[J]. 中国全科医学, 2022, 25(27): 3435-3442.
[5]	谢馨, 陈艳, 何志旭, 黄佩, 陈青华. WASP家族在肿瘤发生发展中作用的研究进展[J]. 中国全科医学, 2022, 25(14): 1779-1789.
[6]	倪嘉淳, 蔡增进, 江琼, 蓝海波, 杨向东, 樊文彬. 药物治疗阿片类药物所致便秘的研究进展[J]. 中国全科医学, 2022, 25(12): 1499-1505.
[7]	李旗，田福玲，郭振宇，周立伟，朱好松. 浮针疗法对轻中度腹泻型肠易激综合征患者内脏敏感性、胃肠动力、肠道菌群及肠黏膜屏障功能的影响研究[J]. 中国全科医学, 2021, 24(9): 1111-1115.
[8]	徐霞，丛妍，何克林，马睿杰. 和胃针法辅助治疗脑瘫患儿睡眠障碍的临床效果研究[J]. 中国全科医学, 2021, 24(9): 1116-1120.
[9]	范尧夫，曹琳，孙洪平，许娟，包薇萍，褚晓秋. 葛根芩连汤治疗2型糖尿病合并非酒精性脂肪性肝病效果的临床研究[J]. 中国全科医学, 2021, 24(36): 4587-4592.
[10]	张东铭，崔婷婷，张锦，曹会芳，王莉梅. 达格列净与利格列汀对2型糖尿病患者代谢指标及PR间期的影响研究[J]. 中国全科医学, 2021, 24(3): 280-284.
[11]	崔伟锋，范军铭，叶静，庆慧. 针刺治疗轻度焦虑症临床疗效的真实世界研究[J]. 中国全科医学, 2021, 24(3): 341-347.
[12]	宋玉芝，甄婵军，白文文，李博，乔学英，周志国. EGFR基因突变阳性肺腺癌脑转移患者治疗后颅内失败的临床研究[J]. 中国全科医学, 2021, 24(29): 3704-3710.
[13]	王慧，赵善坤，刘世雄，李欣. 再次服用阿比特龙治疗转移性前列腺癌的价值[J]. 中国全科医学, 2021, 24(26): 3387-3391.
[14]	付祥真，罗霖，刘奎，田洲舟，蒋莉，陈丽. 不同病因急性呼吸窘迫综合征患者侧卧位与俯卧位通气治疗效果分析[J]. 中国全科医学, 2021, 24(23): 2919-2926.
[15]	於江泉，郑瑞强，朱进，赵媛，杨朋磊. 速度时间积分指导慢性阻塞性肺疾病合并感染性休克患者液体治疗的临床研究[J]. 中国全科医学, 2021, 24(23): 2945-2949.